About KMS Medisurgi Ltd
KMS Medisurgi is produces medical and surgical devices. The Company markets and distributes surgical disposable, hemostat, radiology, oncology, diagnostic, cardiology, critical care, urology, research, and scientific equipment. KMS Medisurgi serves the healthcare industry in India.
Founded
1999
CEO
Sidddharth Kanakia
Employees
20
HQ
Mumbai, Maharashtra
Finished Products
1Surgical products including su
₹13.94Cr2Sale of Finished Goods
₹13.88CrRaw Materials
1Cost of Materials Consumed
₹21.29CrAbout KMS Medisurgi Ltd
KMS Medisurgi is produces medical and surgical devices. The Company markets and distributes surgical disposable, hemostat, radiology, oncology, diagnostic, cardiology, critical care, urology, research, and scientific equipment. KMS Medisurgi serves the healthcare industry in India.
Founded:1999
CEO:Sidddharth Kanakia
Employees:20
HQ:Mumbai, Maharashtra
Finished Products
1Surgical products including su
₹13.94Cr2Sale of Finished Goods
₹13.88CrRaw Materials
1Cost of Materials Consumed
₹21.29CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹133
52W Low
₹127
Volume2.00K
Avg VolumeN/A
BetaN/A
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
179.46x
Valuation
P/B Ratio
5.27x
Valuation
EPS
₹0.74
Valuation
Dividend Yield
0.00%
Valuation
ROE
2.95%
Profitability
ROCE
4.81%
Profitability
Revenue by Segment
Contribution & growth by business line
Healthcare Equipments and SuppliesRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.09x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
8.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.